# Nuclide record pexiretide-tc99m (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/pexiretide-tc99m/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "pexiretide-tc99m" ;
  schema:name "Technetium (99mTc) pexiretide"@en ;
  schema:alternateName "99mTc-3PRGD2"@en, "technetium [99mTc] pexiretide injection"@en, "Jilunte"@en, "3PRGD2"@en, "锝[99mTc]佩昔瑞特加肽注射液"@en, "Jilunte" ;
  schema:description "A Chinese-invented injection that makes tumours visible on the cheap, widely available type of scanner (SPECT) rather than the expensive one (PET). It was approved in China in April 2026 to check whether lung cancer has spread to the lymph nodes."@en ;
  schema:url <https://nuclide.cc/drugs/pexiretide-tc99m/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.nsfc.gov.cn/p1/3381/2825/121910.html>, <https://stcn.com/article/detail/3725436.html>, <https://doi.org/10.3348/kjr.2023.0411>, <https://doi.org/10.3389/fonc.2022.898764> ;
  nuclide:status "approved" ;
  nuclide:tag "diagnostic", "china", "spect", "integrin" ;
  nuclide:modality "Integrin αvβ3-targeted SPECT imaging agent (RGD peptide dimer)" ;
  nuclide:approval "China 2026: SPECT/CT assessment of regional lymph-node metastasis in patients with suspected lung cancer" ;
  nuclide:related <https://nuclide.cc/targets/integrin-avb3/>, <https://nuclide.cc/isotopes/tc-99m/>, <https://nuclide.cc/technologies/spect/>, <https://nuclide.cc/institutions/csnm/>, <https://nuclide.cc/companies/china-isotope-radiation/>, <https://nuclide.cc/journals/chinese-journal-of-nuclear-medicine-and-molecular-imaging/>, <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/nsclc/> .